News & Updates
Filter by Specialty:
Tralokinumab improves skin microbial dysbiosis in atopic dermatitis
In patients with atopic dermatitis (AD), treatment with the IL-13 cytokine-targeting tralokinumab appears to directly or indirectly improves skin microbial dysbiosis, reports a new trial.
Tralokinumab improves skin microbial dysbiosis in atopic dermatitis
10 Dec 2022
Exposure to air pollution ups risk of atopic dermatitis
Long-term exposure to air pollutants, including gases and particulate matter, may increase the risk of developing atopic dermatitis (AD), according to a recent study.
Exposure to air pollution ups risk of atopic dermatitis
07 Dec 2022
Cyclosporin may increase malignancy risk in psoriasis
In psoriasis patients, treatment with cyclosporin may increase the risk of malignancy without nonmelanoma skin cancer, a recent study has found. Biologic or phototherapy have no such impact.
Cyclosporin may increase malignancy risk in psoriasis
07 Dec 2022
Itraconazole effective for ringworm of the body but requires longer treatment
Itraconazole appears to be effective in the treatment of patients with tinea corporis/cruris (TCC) or ringworm of the body, as shown in a study. However, the treatment duration needs to be longer and, even with successful treatment, many patients experience relapse.
